trs85-2 Antibody

What is Trs85 and what cellular processes is it involved in?

Trs85 is a specific subunit of the Transport Protein Particle III (TRAPPIII) complex that functions as a guanine nucleotide exchange factor (GEF) for the small GTPase Ypt1. Research demonstrates that Trs85 plays critical roles in autophagy and vesicular transport pathways. Specifically, Trs85 directs the Ypt1 GEF activity of TRAPPIII to the phagophore assembly site (PAS), which is essential for autophagosome formation . Additionally, Trs85 has been shown to interact directly with Atg9, a transmembrane protein required for autophagosome biogenesis, suggesting its involvement in early stages of autophagy . In plants, the TRAPPC8/TRS85 homolog exhibits similar functions in autophagy while also affecting endoplasmic reticulum stress responses .

How does Trs85 differ structurally and functionally from other TRAPP complex subunits?

Trs85 serves as the defining subunit of the TRAPPIII complex, distinguishing it from other TRAPP complexes. Biochemical fractionation and immunoprecipitation studies have demonstrated that Trs85 associates with the core TRAPP subunits (including Bet3, Trs20, Trs23, Trs31, and Trs33) but does not interact with TRAPPII-specific components such as Trs65, Trs120, and Trs130 . This structural distinction correlates with functional specialization: while TRAPPI and TRAPPII complexes primarily function in ER-Golgi and intra-Golgi trafficking respectively, the Trs85-containing TRAPPIII complex is specifically dedicated to autophagy-related processes . This functional separation is further evidenced by the observation that trs85Δ mutants show normal ER-to-Golgi trafficking of vacuolar protease Prc1, indicating Trs85 is not essential for general secretory pathway function .

What experimental evidence confirms the interaction between Trs85 and Atg9?

Multiple complementary experimental approaches have established the direct interaction between Trs85 and Atg9. Immunoprecipitation studies with Atg9-6xFLAG showed that Trs85 remains associated with Atg9 even after treatment with 0.5% Triton X-100, whereas other proteins like Ypt1 and Atg27 were released, suggesting a direct protein-protein interaction . Yeast two-hybrid assays further confirmed this interaction, specifically demonstrating that the N-terminal half of Trs85 interacts with the N-terminal cytoplasmic domain of Atg9 . Additionally, in vitro binding assays showed that Atg9 vesicles efficiently associated with Trs85-bound beads but not with Trs65-bound beads, despite both containing common TRAPP subunits . This body of evidence collectively establishes that Trs85 serves as a direct binding partner for Atg9 vesicles, independent of other TRAPP complex components.

What are the optimal conditions for using Trs85-2 antibody in immunoprecipitation experiments?

For effective immunoprecipitation of Trs85-containing complexes, researchers should prepare lysates in a stabilizing buffer such as HSE buffer (25 mM HEPES-KOH, pH 7.2, 750 mM sorbitol, and 5 mM EDTA) supplemented with 0.5 mg/ml BSA and 50-250 mM NaCl . When isolating native TRAPP complexes, gentle solubilization with 0.5% Triton X-100 helps maintain protein-protein interactions while releasing membrane-associated complexes . For immunoprecipitation, antibody-conjugated beads (such as IgG-Dynabeads for TAP-tagged Trs85) should be incubated with prepared lysates for 2-3 hours at 4°C to ensure efficient binding while minimizing non-specific interactions . Following immunoprecipitation, washing steps should use buffer containing at least 250 mM NaCl to reduce background while preserving specific interactions. For elution, either competitive elution using peptides (for FLAG-tagged constructs) or protease cleavage (for TAP-tagged proteins) can be employed depending on the experimental design .

How can I validate the specificity of Trs85-2 antibody for immunofluorescence microscopy?

Validating antibody specificity for immunofluorescence requires a multi-faceted approach. First, perform parallel staining in wild-type and trs85Δ cells to confirm signal absence in the deletion strain. Second, compare the localization pattern with fluorescently-tagged Trs85 (such as Trs85-2xGFP) expressed under its native promoter . The antibody signal should show similar punctate structures as observed with Trs85-2xGFP, including partial colocalization with PAS markers like RFP-Ape1 . Third, test antibody specificity in cells overexpressing Trs85, which should show enhanced signal intensity proportional to expression levels. Fourth, perform peptide competition assays where pre-incubation of the antibody with the immunizing peptide should abolish specific staining. Finally, utilize atg14Δ cells where Trs85 accumulates at the PAS as a positive control for enhanced signal localization . This comprehensive validation ensures that the observed patterns truly represent Trs85 localization rather than non-specific binding.

What purification protocol yields the highest purity Trs85-containing complexes for downstream applications?

A high-purity isolation of Trs85-containing complexes can be achieved through sequential affinity purification. For optimal results, express Trs85 with dual tags (such as FLAG and biotin tags) under the control of its native promoter to maintain physiological expression levels . Cell disruption should be performed using mechanical methods like a Multi-beads shocker with zirconia beads in HSE buffer supplemented with protease inhibitors . Following centrifugation at 50,000 × g for 20 minutes at 4°C, incubate the supernatant with anti-FLAG antibody-bound beads for 3 hours at 4°C . After washing with HSE buffer containing 250 mM NaCl, elute with 3xFLAG peptide (2 mg/ml) . For the second purification step, incubate the eluate with streptavidin beads to capture biotinylated Trs85 complexes . This two-step purification significantly reduces non-specific contaminants while preserving native protein interactions. For specific isolation of intact TRAPPIII complexes, size exclusion chromatography following affinity purification further separates Trs85-containing TRAPPIII from other TRAPP complexes, as demonstrated by their distinct elution profiles .

How can Trs85-2 antibody be used to study the temporal dynamics of autophagosome formation?

Trs85-2 antibody can effectively track the temporal dynamics of autophagosome formation through time-resolved immunofluorescence microscopy combined with careful colocalization analysis. Design an experimental time course following autophagy induction with rapamycin and collect samples at defined intervals (e.g., 15, 30, 60, 120 minutes). At each timepoint, perform multi-color immunofluorescence using Trs85-2 antibody alongside markers for sequential stages of autophagosome formation, such as Atg9, Atg14 (PI3K complex), and Atg8 (mature autophagosomes) . Quantitative colocalization analysis will reveal how Trs85 association with these different markers changes over time. Research has shown that Trs85 colocalizes with RFP-Ape1 at the PAS in approximately 31% of rapamycin-treated cells and that this colocalization is dependent on Atg9 . This temporal profiling can further elucidate how Trs85 coordinates the sequential recruitment of autophagy proteins to the PAS, particularly its role in recruiting the Atg14-containing PI3K complex, which is significantly reduced in trs85Δ cells .

What approaches can distinguish between TRAPPIII-dependent and TRAPPIII-independent functions of Trs85 using antibody-based techniques?

Distinguishing between TRAPPIII-dependent and potential TRAPPIII-independent functions of Trs85 requires sophisticated antibody-based approaches. One effective strategy involves sequential immunodepletion experiments: first deplete all TRAPPIII complexes using antibodies against core TRAPP subunits (such as Bet3 or Trs33), then probe the depleted lysate with Trs85-2 antibody to detect any remaining free Trs85 pools. Additionally, proximity ligation assays (PLA) can map the spatial relationships between Trs85 and other TRAPP subunits versus Trs85 and autophagy-specific proteins like Atg9 . Biochemical fractionation studies have shown that Trs85 coprecipitates with Trs33 and Trs20 but not with TRAPPII-specific components (Trs65, Trs130, Trs120), supporting its integration in a distinct TRAPPIII complex . Furthermore, comparing phenotypes of trs85Δ mutants with deletion mutants of core TRAPP subunits can reveal functions specific to Trs85. For instance, while core TRAPP subunits affect both autophagy and secretory pathways, trs85Δ specifically impairs autophagy without significantly affecting the trafficking of vacuolar protease Prc1 through the Golgi complex .

How can I use Trs85-2 antibody to investigate the relationship between autophagy and endoplasmic reticulum stress?

Recent research in Arabidopsis has revealed an unexpected connection between TRAPPC8/TRS85 function, autophagy, and endoplasmic reticulum (ER) stress . To investigate this relationship, design a comprehensive immunoprecipitation study using Trs85-2 antibody under normal, starvation-induced autophagy, and ER stress conditions. Analyze the immunoprecipitated complexes by mass spectrometry to identify condition-specific interaction partners. Complement this approach with immunofluorescence studies examining Trs85 colocalization with both autophagy markers and ER stress indicators like Bip/Kar2. Arabidopsis trappc8 mutants exhibit both autophagic defects and a constitutive ER stress response, suggesting a functional link . Additionally, measure autophagy flux using established assays in cells experiencing ER stress with and without functional Trs85. The elevation of dolichol levels in trappc8 mutants suggests a potential mechanism connecting Trs85 function to protein glycosylation and ER homeostasis . This integrated approach can reveal how Trs85 might coordinate responses to different cellular stresses through its involvement in both autophagy and ER function.

What factors might explain discrepancies in Trs85 localization reported in different studies?

Discrepancies in Trs85 localization across studies can stem from multiple methodological and biological factors. One significant factor is the dynamic and often transient nature of Trs85 localization - studies have demonstrated that "only a minor, but significant portion of Trs85-2xGFP does indeed colocalize with RFP-Ape1 in rapamycin-treated cells" . This partial colocalization (approximately 31% of Ape1 puncta) means that different sampling methods or timepoints could yield seemingly contradictory results. Additionally, variation in the genetic background of yeast strains influences Trs85 localization – for instance, Trs85 PAS localization is enhanced in atg14Δ cells (47% colocalization) where Atg9 accumulates at the PAS . Technical factors like fixation methods, antibody sensitivity, and detection thresholds also contribute to discrepancies. Some studies may fail to detect the PAS pool of Trs85 due to its relatively low abundance compared to cytosolic or other membrane-associated pools. Finally, differences in autophagy induction methods (nitrogen starvation versus rapamycin treatment) can affect the timing and extent of Trs85 recruitment to the PAS. Researchers should carefully consider these factors when comparing localization data across studies.

How can I interpret negative results when attempting to detect protein interactions with Trs85 using co-immunoprecipitation?

Negative co-immunoprecipitation results with Trs85 warrant careful interpretation through several analytical perspectives. First, consider the lability of the interaction – some Trs85 interactions, particularly with membrane proteins like Atg9, may require specialized buffer conditions to maintain. While Trs85 remains associated with Atg9 after Triton X-100 treatment, other interactions may be more sensitive to detergent . Second, evaluate temporal dynamics – interactions may be transient or condition-specific, as seen with enhanced Trs85-PAS association after rapamycin treatment . Third, assess protein abundance – low-abundance interactors may fall below detection thresholds in standard co-IP experiments. Fourth, consider post-translational modifications that might regulate interactions – phosphorylation states could affect binding affinity. Fifth, examine steric hindrance – epitope tags or antibody binding may interfere with specific protein interactions. To address these possibilities, employ complementary approaches such as proximity labeling (BioID), crosslinking mass spectrometry, or yeast two-hybrid assays. Remember that even well-characterized interactions like Trs85-Atg9 show context-specific behaviors – for example, full-length Trs85 does not show positive interactions in yeast two-hybrid assays, while its N-terminal half does interact with Atg9 .

What control experiments are essential when using Trs85-2 antibody to study autophagy defects?

When investigating autophagy defects using Trs85-2 antibody, several critical control experiments ensure result validity and interpretability. First, include genetic controls: compare wild-type, trs85Δ, and complemented strains (trs85Δ + Trs85) to establish phenotype specificity. Second, implement domain-specific controls by creating point mutations in Trs85 functional domains, particularly the N-terminal region that interacts with Atg9 . Third, include related protein controls by examining other TRAPP complex members – for instance, determining whether the phenotype is specific to Trs85 or shared with trs33Δ mutants . Fourth, establish assay-specific controls for autophagy measurements, including positive controls (atg1Δ for complete autophagy block) and negative controls (normal autophagy induction in wild-type cells). Fifth, conduct epistasis analysis with other autophagy genes – particularly informative are double mutants like trs85Δ atg11Δ atg17Δ, which help position Trs85 function in the autophagy pathway . Finally, include physiological controls by measuring autophagy under different induction methods (nitrogen starvation versus rapamycin), as Trs85 requirement may vary with induction mechanism. Research has shown that while trs85Δ cells exhibit complete defects in the Cvt pathway, they show only partial defects in non-specific autophagy, highlighting the importance of condition-specific controls .

How might next-generation antibody techniques advance our understanding of Trs85's role in selective versus non-selective autophagy?

Next-generation antibody techniques offer promising approaches to dissect Trs85's differential roles in selective and non-selective autophagy. Single-molecule immunofluorescence techniques, such as stochastic optical reconstruction microscopy (STORM) combined with Trs85-specific antibodies, could reveal nanoscale organization differences at the PAS during selective versus non-selective autophagy. Research has already established that trs85Δ cells show complete defects in the selective Cvt pathway while exhibiting only partial defects in non-selective autophagy , suggesting functional specialization. Intrabodies (intracellularly expressed antibody fragments) against specific Trs85 domains could be engineered to inhibit distinct Trs85 interactions in living cells, enabling temporal control over specific functions. Additionally, split-fluorescent protein complementation using anti-Trs85 nanobodies fused to fragments of fluorescent proteins could visualize specific Trs85 conformational states or interactions in real-time during different types of autophagy. Multiplexed epitope tagging approaches targeting different regions of Trs85 might also reveal condition-specific conformational changes. These advanced techniques could help resolve how Trs85 coordinates the specific requirements of different autophagy pathways, potentially through distinct interaction partners or regulatory mechanisms.

What research questions regarding Trs85 function in plant autophagy remain unexplored?

Recent identification of TRAPPC8/TRS85 function in Arabidopsis has opened several unexplored research directions . First, the mechanistic connection between TRAPPC8/TRS85 function and dolichol accumulation remains poorly understood – does plant TRAPPC8 directly regulate dolichol biosynthesis or trafficking, or is dolichol accumulation a secondary effect of disrupted membrane homeostasis? Second, while Arabidopsis trappc8 mutants show both autophagy defects and constitutive ER stress , the causal relationship between these phenotypes requires further investigation. Third, the evolutionary conservation of TRAPPC8/TRS85 interactions needs comparative analysis – does plant TRAPPC8 directly interact with ATG9 as observed in yeast , or has this interaction diversified? Fourth, the role of TRAPPC8/TRS85 in plant-specific selective autophagy pathways, such as chlorophagy (degradation of chloroplasts) or proteaphagy (degradation of proteasomes), remains entirely unexplored. Fifth, how environmental stresses affect TRAPPC8/TRS85 function in plants could reveal adaptive mechanisms unique to plant systems. Finally, the developmental abnormalities observed in trappc8 mutants, particularly in flower and seed development , suggest plant-specific functions that may extend beyond the canonical autophagy pathway. Addressing these questions will require plant-specific Trs85 antibodies and genetic tools adapted to the unique challenges of plant cell biology.

How can integrative multi-omics approaches incorporating Trs85-2 antibody techniques advance our understanding of TRAPPIII complex regulation?

Integrative multi-omics approaches combined with Trs85-2 antibody techniques can revolutionize our understanding of TRAPPIII complex regulation. Immunoprecipitation using Trs85-2 antibody followed by quantitative proteomics under various conditions (nutrient availability, stress, cell cycle stages) can identify condition-specific TRAPPIII interactors and post-translational modifications. This proteomics data can be integrated with phosphoproteomics to map regulatory phosphorylation networks controlling Trs85 function. Complementary chromatin immunoprecipitation sequencing (ChIP-seq) and RNA-seq analyses can reveal transcriptional mechanisms regulating TRAPPIII complex components across conditions. Additionally, Trs85 immunoprecipitation coupled with lipidomics analysis could address whether Trs85/TRAPPIII directly influences membrane lipid composition, particularly relevant given the elevated dolichol levels observed in Arabidopsis trappc8 mutants . Spatial transcriptomics and single-cell approaches incorporating Trs85 immunostaining could map tissue-specific regulation of TRAPPIII. These multi-omics datasets can be integrated through computational systems biology approaches to generate predictive models of TRAPPIII regulation. This integrated approach would address fundamental questions about how cells coordinate TRAPPIII activity with metabolic state, stress responses, and developmental programs – particularly important given TRAPPC8/TRS85's involvement in both canonical autophagy and apparently distinct processes like ER stress response and dolichol metabolism .

Table 1: Comparative Analysis of Trs85 Colocalization with Autophagy Markers Under Different Conditions

Table 2: Molecular Interactions of Trs85 Established Through Different Experimental Approaches